SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-23-112496
Filing Date
2023-10-30
Accepted
2023-10-30 13:42:49
Documents
2
Group Members
ANTOINE PAPIERNIKCEDRIC MOREAUJACQUES THEURILLATJOSEPH ANDERSONKINAM HONGSOFINNOVA PARTNERS SAS

Document Format Files

Seq Description Document Type Size
1 SC 13D tm2329348d1_sc13d.htm SC 13D 104800
2 EXHIBIT 99.1 tm2329348d1_ex99-1.htm EX-99.1 12785
  Complete submission text file 0001104659-23-112496.txt   119154
Mailing Address 7-11 BOULEVARD HAUSSMAN PARIS I0 75009
Business Address 7-11 BOULEVARD HAUSSMAN PARIS I0 75009 33 (0) 1 76 23 41 00
Sofinnova Crossover I (Filed by) CIK: 0001845105 (see all company filings)

IRS No.: 981420904 | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 7 BD HAUSSMANN PARIS I0 75009
Business Address 7 BD HAUSSMANN PARIS I0 75009 01 53 83 09 63
Abivax S.A. (Subject) CIK: 0001956827 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-94198 | Film No.: 231359397
SIC: 2834 Pharmaceutical Preparations